References
- Alam, S.E., Nasser, S.S., Fernainy, K.E., Habib, A.A., Badr, K.F. (2004). Cytokine imbalance in acute coronary syndrome. Curr. Opin. Pharmacol., 4(2), 166-170.10.1016/j.coph.2003.10.011
- Alberti, K.G., Zimet, P., Shaw, J. (2005). The metabolic syndrome — a new worldwide definition. Lancet, 366(9491), 1059-1062.
- Avanzas, P., Arroyo-Espliguero, R., Cosķn-Sales, J., Aldama, G., Pizzi, C., Quiles, J., Kaski, J.C. (2004a). Markers of inflammation and multiple complex stenoses (pancoronary plaque vulnerability) in patients with non-ST segment elevation acute coronary syndromes. Heart, 90, 847-852.10.1136/hrt.2003.015826
- Avanzas, P., Arroyo-Espliguero, R., Cosin-Sales, J., Quiles, J., Zouridakis, E., Kaski, J.C. (2004b). Prognostic value of neopterin levels in treated patients with hypertension and chest pain but without obstructive coronary artery disease. Amer. J. Cardiol., 93, 627-629.10.1016/j.amjcard.2003.11.035
- Avanzas, P., Arroyo-Espliguero, R., Quiles, J., Roy, D., Kaski, J.C. (2005). Elevated serum neopterin predicts future adverse cardiac events in patients with chronic stable angina pectoris. Eur. Heart. J., 26(5), 457-463.10.1093/eurheartj/ehi111
- Baldus S., Heeschen C., Meinertz T., Zeiher A.M., Eiserich J.P., Munzel T., Simoons M.L., Hamm C.Q., CAPTURE Investigators. (2003). Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation, 108, 1440-1445.10.1161/01.CIR.0000090690.67322.51
- Balogh A., Mittermayr M., Schlager A., Balogh D., Schobersberger W., Fuchs D., Margreiter J. (2005). Mechanism of neopterin-induced myocardial dysfunction in the isolated perfused rat heart. Biochim. Biophys. Acta, 1724(1-2), 17-22.10.1016/j.bbagen.2005.04.006
- Blankenberg, S., Barbaux, S., Tiret, L. (2003) Adhesion molecules and atherosclerosis. Atherosclerosis, 170, 191-203.10.1016/S0021-9150(03)00097-2
- Blankenberg, S., Rupprecht, H.J., Bickel, C. (2001). Circulating cell adhesion molecules and death in patients with coronary artery disease. Circulation, 104, 1336-1342.10.1161/hc3701.09594911560847
- Braunwald, E. (1989). Unstable angina: A classification. Circulation, 80, 410-414.10.1161/01.CIR.80.2.4102752565
- Brennan M.L., Penn M.S., van Lente F., Nambi V., Shishehbor M.H., Aviles R.J., Goormastic M., Pepoy M.L., McErlean, E.S., Topol, E.J., Nissen, S.E., Hazen, S.L. (2003) Prognostic value of myeloperoxydase in patients with chest pain. N. Engl. J. Med., 349, 1595-1604.
- Burke, A.P., Tracy, R.P., Kolodgie, F., Malcom, G.T., Zieske, A., Kutys, R., Pestaner, J., Smialek, J., Virmani, R. (2002). Elevated C-reactive protein values and atherosclerosis in sudden coronary death: Association with different pathologies. Circulation, 105, 2019-2023.10.1161/01.CIR.0000015507.29953.38
- Cirillo, P., Pacileo, M., de Rosa, S., Calabrņ, P., Gargiulo, A., Angri, V., Granato-Corigliano, F., Fiorentino, I., Prevete, N., de Palma, R., Mauro, C., Leonardi, A., Chiariello, M. (2006). Neopterin induces pro-atherothrombotic phenotype in human coronary endothelial cells. J. Thromb. Haemost., 4(10), 2248-2255.10.1111/j.1538-7836.2006.02125.x16842491
- Constans, J., Conri, C. (2006). Circulating markers of endothelial function in cardiovascular disease. Clin. Chim. Acta, 368(1-2), 33-47.10.1016/j.cca.2005.12.03016530177
- Eschen, O., Christensen, J.H., Toft, E., Schmidt, E.B. (2005). Soluble adhesion molecules and marine n-3 fatty acids in patients referred for coronary angiography. Atherosclerosis, 180(2), 327-331.10.1016/j.atherosclerosis.2004.12.00615910859
- Estévez-Loureiro, R., Recio-Mayoral, A., Sieira-Rodrķguez-Moret, J.A., Trallero-Araguis, E., Kaski, J.C. (2009). Neopterin levels and left ventricular dysfunction in patients with chronic stable angina pectoris. Atherosclerosis, 207(2), 514-518.10.1016/j.atherosclerosis.2009.04.03219577753
- Gonzalez, M.A., Selwyn, A.P. (2003). Endothelial function, inflammation, and prognosis in cardiovascular disease. Amer. J. Med., 115(Suppl. 8A), 99S-106S.10.1016/j.amjmed.2003.09.01614678874
- Heslop, C.L., Frohlich, J.J., Hill, J.S. (2010). Myeloperoxidase and C-reactive protein have combined utility for long-term prediction of cardiovascular mortality after coronary angiography. J. Amer. Coll. Cardiol., 55(11), 1102-1109.10.1016/j.jacc.2009.11.05020223364
- Huber, C., Batchelor, J.R., Fuchs, D., Hausen, A., Lang, A., Niederwieser, D., Reibnegger, G., Swetly, P., Troppmair, J., Wachter, H. (1984) Immune response-associated production of neopterin: Release from macrophages primarily under control of interferon-gamma. J. Exp. Med., 160, 310-316.10.1084/jem.160.1.31021874256429267
- Hwang, S.J, Ballantyne, C.M., Sharrett, A.R, (1997). Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: The atherosclerosis risk in communities (ARIC) study. Circulation, 96, 4219-4225.10.1161/01.CIR.96.12.4219
- Kaski, J.C., Consuegra-Sanchez, L., Fernandez-Berges, D.J., Cruz-Fernandez, J.M., Garcia-Moll, X., Marrugat, J., Mostaza, J., Toro-Cebada, R., Gonzilez-Juanatey, J.R., Guzmin-Martķnez, G.; SIESTA Investigators. (2008). Elevated serum neopterin levels and adverse cardiac events at 6 months follow-up in Mediterranean patients with non-ST-segment elevation acute coronary syndrome. Atherosclerosis, 201(1), 176-183.10.1016/j.atherosclerosis.2008.01.00918336825
- Kressel, G., Trunz, B., Bub, A., Hülsmann, O. (2009). Systemic and vascular markers of inflammation in relation to metabolic syndrome and insulin resistance in adults with elevated atherosclerosis risk. Atherosclerosis, 202(1). 263-271.10.1016/j.atherosclerosis.2008.04.01218501910
- Miwa, K., Igawa, A., Inoue, H. (1997). Soluble E-selectin, ICAM-1 and VCAM-1 levels in systemic and coronary circulation in patients with variant angina. Cardiovasc. Res., 36, 37-44.10.1016/S0008-6363(97)00143-0
- Mizia-Stec, K., Zahorska-Markiewicz, B., Mandecki, T., Janowska, J., Szulc, A., Jastrzebska-Maj, E. (2002). Serum levels of selected adhesion molecules in patients with coronary artery disease. Int. J. Cardiol., 83(2), 143-150.10.1016/S0167-5273(02)00032-3
- Murr, C., Winklhofer-Roob, B.M., Schroecksnadel, K., Maritschnegg, M., Mangge, H., Böhm, B.O., Winkelmann, B.R., März, W., Fuchs, D. (2009). Inverse association between serum concentrations of neopterin and antioxidants in patients with and without angiographic coronary artery disease. Atherosclerosis, 202(2), 543-549.10.1016/j.atherosclerosis.2008.04.047
- Nicholls, S., Hazen, S. (2005). Myeloperoxidase and cardiovascular disease. Arterioscler. Thromb. Vasc. Biol., 25, 1102-1111.10.1161/01.ATV.0000163262.83456.6d
- Peter, K., Nawroth, P., Conradt, C. (1997). Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin. Arterioscler. Thromb. Vasc. Biol., 17, 505-512.10.1161/01.ATV.17.3.505
- Pigo, R., Dillon, L.P., Hemingway, I.H., Gearing, A.J. (1992). Soluble forms of Eselectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biochem. Biophys. Res. Commun., 187, 584-589.10.1016/0006-291X(92)91234-H
- Ridker, P.M., Hennekens, C.H., Roitman-Johnson, B., Stampfer, M.J., Allen, J. (1998). Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet, 351, 88-92.10.1016/S0140-6736(97)09032-6
- Roman, R.M., Camargo, P.V., Borges, F.K., Rossini, A.P., Polanczyk, C.A. (2010) Prognostic value of myeloperoxidase in coronary artery disease: Comparison of unstable and stable angina patients. Coron. Artery Dis., 21(3), 129-136.10.1097/MCA.0b013e328333f50d20305551
- Roman, R.M., Camargo, P.V., Borges, F.K., Rossini, A.P., Polanczyk, C.A. (2010). Prognostic value of myeloperoxidase in coronary artery disease: Comparison of unstable and stable angina patients. Coron. Artery. Dis., 21(3), 129-136.10.1097/MCA.0b013e328333f50d
- Rudolph, V., Goldmann B.U., Bös C., Rudolph T.K., Klinke A., Friedrichs K., Lau D., Wegscheider K., Haddad, M., Meinertz, T., Baldus, S. (2010). Diagnostic value of MPO plasma levels in patients admitted for suspected myocardial infarction. Int. J. Cardiol., [Epub ahead of print].
- Ruotsalainen, E., Vauhkonen, I., Salmenniemi, U., Pihlajamäki, J. (2008). Markers of endothelial dysfunction and low-grade inflammation are associated in the offspring of type 2 diabetic subjects. Atherosclerosis, 197(1), 271-277.10.1016/j.atherosclerosis.2007.04.02117560580
- Schindhelm, R.K., van der Zwan, LP., Teerlink T., Scheffer. P.G. (2009). Myeloperoxidase: A useful biomarker for cardiovascular disease risk stratification? Clin Chem., 55(8), 1462-1470.10.1373/clinchem.2009.126029
- Schumacher, M., Halwachs, G., Tatzber, F., Fruhwald, F.M., Zweiker, R., Watzinger, N. (1997). Increased neopterin in patients with chronic and acute coronary syndromes. J. Amer. Coll. Cardiol., 30, 703-707.10.1016/S0735-1097(97)00172-1
- van der Meer, I., de Maat, M.P., Bots, M.L. (2002). Inflammatory mediators and cell adhesion molecules as indicators of severity of atherosclerosis: The Rotterdam study. Arterioscler. Thromb. Vasc. Biol., 22, 838-842.10.1161/01.ATV.0000016249.96529.B8
- Wirleitner, B., Baier-Bitterlich, G., Hoffmann, G., Schobersberger, W., Wachter, H., Fuchs, D. (1997) Neopterin derivatives to activate NF-kappa B. Free Radic. Biol. Med., 23, 177-179.
- Zakynthinos, E., Pappa, N. (2009). Inflammatory biomarkers in coronary artery disease. J. Cardiol., 53(3), 317-333.10.1016/j.jjcc.2008.12.00719477372
- Zhang, R., Brennan, M.L., Fu, X., Aviles, R.J., Pearce, G.L., Penn, M.S., Topol E.J., Sprecher, D.L., Hazen, S.L. (2001). Association between myeloperoxidase levels and risk of coronary artery disease. J. Amer. Med. Assoc., 286, 2136-2142.10.1001/jama.286.17.213611694155
- Zouridakis, E., Avanzas, P., Arroyo-Espliguero, R., Fredericks, S., Kaski, J.C. (2004). Markers of inflammation and rapid coronary artery disease progression in patients with stable angina pectoris. Circulation, 110, 1747-1753.10.1161/01.CIR.0000142664.18739.9215381646